Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M140,881Revenue $M45,625Net Margin (%)11.2Z-Score0
Enterprise Value $M140,881EPS $1.9Operating Margin %15.3F-Score0
P/E(ttm))27.9Cash Flow Per Share $7.2Pre-tax Margin (%)13.8Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %3.9Quick Ratio0Cash flow > EarningsN
Price/Sales3.25-y EBITDA Growth Rate %-2.0Current Ratio0Lower Leverage y-yN
Price/Cash Flow6.5y-y EBITDA Growth Rate %25.9ROA % (ttm)3.9Higher Current Ratio y-yN
Dividend Yield %3.6Insider Buy (3m)0ROE % (ttm)6.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M2,649ROI % (ttm)4.2Gross Margin Increase y-yN

Gurus Latest Trades with SNY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNYJohn Hussman 2014-06-30 Sold Out -0.09%$51.23 - $54.54
($53.08)
$ 53.070%Sold Out0
SNYScott Black 2014-03-31 Buy 1.4%$47.77 - $53.63
($50.64)
$ 53.075%New holding, 247100 sh.247,100
SNYJames Barrow 2014-03-31 Add0.39%$47.77 - $53.63
($50.68)
$ 53.075%Add 22.72%27,790,116
SNYCharles Brandes 2013-12-31 Add0.2%$48.75 - $54
($51.57)
$ 53.073%Add 18.29%2,013,300
SNYMario Gabelli 2013-12-31 Reduce$48.75 - $54
($51.57)
$ 53.073%Reduce -24.37%4,500
SNYJames Barrow 2013-09-30 Add1.29%$47.64 - $53.24
($50.87)
$ 53.074%Add 312.86%21,466,988
SNYMario Gabelli 2013-09-30 Add$47.64 - $53.24
($50.87)
$ 53.074%Add 32.22%5,950
SNYMario Gabelli 2013-06-30 Buy $49.77 - $55.64
($53.28)
$ 53.070%New holding, 4500 sh.4,500
SNYCharles Brandes 2013-06-30 Reduce-0.26%$49.77 - $55.64
($53.28)
$ 53.070%Reduce -20.35%1,713,266
SNYCharles Brandes 2012-09-30 Reduce-0.41%$36.81 - $44.6
($40.57)
$ 53.0731%Reduce -25.37%2,982,819
SNYDavid Dreman 2012-09-30 Sold Out -0.09%$36.81 - $44.6
($40.57)
$ 53.0731%Sold Out0
SNYJohn Hussman 2012-06-30 Add$33.4 - $39.06
($35.98)
$ 53.0748%Add 22.62%27,100
SNYPRIMECAP Management 2012-03-31 Add0.08%$35.32 - $38.92
($35.05)
$ 53.0751%Add 141.26%2,222,692
SNYJames Barrow 2011-12-31 Add0.08%$31.72 - $37.45
($34.48)
$ 53.0754%Add 26.83%4,501,475
SNYGeorge Soros 2011-12-31 Sold Out -0.11%$31.72 - $37.45
($34.48)
$ 53.0754%Sold Out0
SNYJames Barrow 2011-09-30 Add0.13%$31.5 - $40.08
($35.94)
$ 53.0748%Add 83.96%3,549,200
SNYGeorge Soros 2011-09-30 Buy 0.11%$31.5 - $40.08
($35.94)
$ 53.0748%New holding, 201400 sh.201,400
SNYDodge & Cox 2011-06-30 Add0.16%$35.68 - $40.58
($38.04)
$ 53.0740%Add 6.63%54,287,695
SNYJames Barrow 2011-06-30 Add0.05%$35.68 - $40.58
($38.04)
$ 53.0740%Add 43.65%1,929,300
SNYDavid Dreman 2011-06-30 Add0.02%$35.68 - $40.58
($38.04)
$ 53.0740%Add 38.36%96,767
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SNY Scott Black 2014-03-31247,1000.011.4New Buy
SNY James Barrow 2014-03-3127,790,1161.052.1+22.72%
SNY PRIMECAP Management 2014-03-312,476,8560.090.15+8.58%
SNY Charles Brandes 2014-03-312,072,7900.081.4+2.95%
SNY Dodge & Cox 2014-03-3143,664,8871.652.3+0.08%
SNY Mario Gabelli 2014-03-314,50000
SNY John Hussman 2014-03-3122,10000.09
SNY Warren Buffett 2014-03-313,905,8750.150.19
SNY Jean-Marie Eveillard 2014-03-31610,7490.020.09-6.68%
Premium Most recent portfolio changes are included for Premium Members only!


SNY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanofi10% Owner 2014-03-25Buy344,448$66.88-21.98view
Sanofi10% Owner 2014-02-04Buy1,303,780$7.67580.31view

Press Releases about SNY :

    Quarterly/Annual Reports about SNY:

      News about SNY:

      Articles On GuruFocus.com
      George Soros Reveals His Largest Stake Jul 23 2014 
      Health Care Sector in an Upward Climb in June Jun 12 2014 
      Sarah Ketterer’s Causeway International Value’s Top Five Holdings Jun 05 2014 
      Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks May 29 2014 
      Oakmark's Bill Nygren Discusses Financials, Favorite Stocks Apr 15 2014 
      Bill Nygren Comments on Sanofi Apr 08 2014 
      Bill Nygren's Oakmark Fund First Quarter 2014 Commentary Apr 08 2014 
      Sanofi's Getting Back in the Game Mar 25 2014 
      Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks Mar 12 2014 
      Warren Buffett Shows Changes to International Holdings: Tesco, Munich Re, Sanofi, POSCO Mar 06 2014 


      More From Other Websites
      Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
      Sanofi and Regeneron Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
      Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission Jul 30 2014
      Midday movers: Hess, Twitter, Valero Eneregy & More Jul 30 2014
      Amgen Restructuring Plan, Q2 Earnings Send Stock Up Jul 30 2014
      Regeneron shares jump after cholesterol drug meets test goals Jul 30 2014
      Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
      Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
      8:01 am Sanofi-Aventis and Regeneron (REGN) report positive... Jul 30 2014
      Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
      Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in... Jul 30 2014
      [video] Lucy Beats Greek Hero Hercules At Box Office Debut Jul 28 2014
      Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United... Jul 22 2014
      Salix-Pharming's Ruconest Gets FDA Nod for HAE Jul 18 2014
      InterMune's (ITMN) Esbriet Gets Breakthrough Designation Jul 18 2014
      3 Stocks Pushing The Drugs Industry Lower Jul 17 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide